PRZOOM - /newswire/ -
Waukesha, WI, United States, 2010/02/04 - GE Healthcare announced today that Dr. William (Pepper) Denman has been appointed Chief Medical Officer (CMO) at GE Healthcare, a unit of General Electric Company (NYSE: GE). NYSE: GE
Dr. Denman is the former Chief Medical Officer and Vice President, Medical Affairs for Covidien, where he was responsible for strategic direction of medical affairs, clinical affairs and healthcare economics and outcomes across Covidien’s entire medical device sector. Denman is currently involved in multiple clinical and basic science research projects at Massachusetts General Hospital and Harvard Medical School. He received his Doctor of Medicine at the University of Aberdeen (United Kingdom).
The GE Healthcare Chief Medical Officer is the most senior physician in the company, with primary responsibility for all matters of patient safety. Dr. Denman will provide the clinical direction for GE, working with the Global Quality, Regulatory and Medical organization to improve process rigor around clinical trial design, academic research partnerships, and medical risk assessments. Dr. Denman also will lead all clinical and evidence generation strategies, driving technology and scientific synergies across all of GE Healthcare.
“Pepper is a great addition to GE Healthcare,” said John Dineen, President and CEO of GE Healthcare. “Dr. Denman’s leadership will help focus us on technologies that deliver better clinical outcomes and better healthcare economics.”
Denman will be part of GE Healthcare’s newly expanded Global Quality, Regulatory & Medical organization, led by Chief Quality Officer Dee Mellor.
“The depth of Dr. Denman’s medical expertise, his general management experience and proven leadership skills makes him ideally suited to take on the challenges of this critical role,” said Mellor. “Dr. Denman will help us deliver GE Healthcare’s healthymagination strategy of lowering costs, increasing access and improving quality.”
About GE Healthcare
GE Healthcare (gehealthcare.com) provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website.